Atlas Trials

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970g

Clinical trial NCT00404157 · WITHDRAWN

Trial details

NCT number
NCT00404157
Sponsor
Genentech, Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Lupus Nephritis
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.